Ldl - Open Access .click

Results 41 to 50 of about 416,899 (301)

A correlative study of uric acid with lipid profile

Asian Journal of Medical Sciences, 2013
Objective: the study was conducted to verify the association of hyperuricemia with lipid profile in a group of Assamese people so as to take necessary precautions from developing future cardiovascular disease (CVD).
Devajit Sarmah
doaj +1 more source

LDL-C goal achievement rates based on the 2015 Korean guidelines and LDL-C distributions categorized by the use of lipid-modifying treatment.

, 2020
LDL-C, low-density lipoprotein cholesterol; LMT, lipid-modifying treatment.
Siin Kim (3949709) +5 more
core +1 more source

Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study) [PDF]

Endocrinology and Metabolism, 2020
Background While randomized controlled trials provide useful information about drug safety and efficacy, they do not always reflect the observed results in the real world.
In-Kyung Jeong, Sung-Rae Kim
doaj +1 more source

PCSK9: A Key Target for the Treatment of Cardiovascular Disease (CVD) [PDF]

Advanced Pharmaceutical Bulletin, 2020
Proprotein convertase subtilisin/kexin type 9 (PCSK9), as a vital modulator of low-density lipoprotein cholesterol (LDL-C) , is raised in hepatocytes and released into plasma where it binds to LDL receptors (LDLR), leading to their cleavage.
Saeideh Sobati +6 more
doaj +1 more source

Global Burden of Elevated LDL-C [PDF]

Importance Elevated low-density lipoprotein cholesterol (LDL-C) is a modifiable risk factor for cardiovascular disease, the leading cause of premature death worldwide.
Kwanghyun Kim +999 more
core +1 more source

Effect of DFPP on Ferroptosis in Peripheral Blood CD14+ Monocytes of Hyperlipidemic Patients Involving the ACSL4/LPCAT3/ALOX5 Pathway

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng, Lan Li, Qingmei Yang, Meipeng Wu +3 more
wiley +1 more source

Relationship between behcets disease and oxidant and antioxidant markers

Medicine Science, 2020
Behcets disease is known as a chronic and inflammatory vasculitis with multiple system and organ involvement. In this study, we aimed to evaluate the relationship between BD and oxidative stress by evaluating the total antioxidant status (TAS), total ...
Fikret Akyurek, Fatma Tuncez Akyurek
doaj +1 more source

Ox-LDL-mediated repletion of ATP6V₀d2-KD cholesterol levels restores PV volumes and impacts parasite multiplication.

, 2019
A. Intracellular cholesterol levels displayed by nonsilenced or ATP6V0d2-KD macrophages treated or not with 50 μg/ml of ox-LDL for 48 hours, showing that ox-LDL replenishes the ~40% lower cholesterol amount of ATP6V0d2-KD to levels comparable to ...
Luiza Campos Reis (6843587) +11 more
core +1 more source

In silico and in vitro exploration of a tyrosinase for biocatalytic production of catechols

FEBS Open Bio, EarlyView.
Tyrosinase from Ralstonia pseudosolanacearum is a promising biocatalyst for producing valuable catechols from monophenol substrates. This tyrosinase is uniquely suited to this due to its high monophenolase : diphenolase ratio. We combined in silico docking and in vivo kinetic characterisation of this tyrosinase with 11 industrially relevant monophenols,
James Britton +6 more
wiley +1 more source

Lipoprotein-associated phospholipase A2 in relation to lipid markers: A pan-India correlation study

Asian Journal of Medical Sciences, 2019
Background: Conventional serum markers are routinely recommended to assess heart health. However, many new biochemical markers like lipoprotein-associated phospholipase A2 (Lp-PLA2) has been studied as an efficient cardiac risk marker.
Sandhya Iyer +4 more
doaj +1 more source

hdl
cholesterol
atherosclerosis

triglycerides
lipoproteins
dyslipidemia

total cholesterol
triglyceride
vldl